infections: aspartyl protease potential to improve outcome in susceptible hosts.

UNLABELLED

Though a confined or a broad population is exposed respectively to endemic or pandemic infections, in the same environment, some individuals resist the development of infections. The attributed reason is the inheritance of a set of immune system genes that can efficiently deal with the pathogens. In this study, we show how outbred mice differentially respond to a fungal pathogen, and the mechanism through which the surviving mice mount a protective immune defense. We identified that those mice developing antibodies specifically against Pep1p, an aspartic protease secreted by , had significantly improved survival. Vaccination (either prophylactic or therapeutic) with a recombinant Pep1p significantly increased the survival of the mice by decreasing the fungal load and stimulating a protective immune response. Passive immunization of infected mice with monoclonal antibodies developed against Pep1p also improves the survival of the mice by increasing phagocytosis of and decreasing the multiplication of this fungus. Together, these data demonstrate the prophylactic and therapeutic potentials of the antigenic protein Pep1p or Pep1p-specific antibodies against this fungal infection. Also, this study suggests that the immunological interaction and thereby the responses developed against a pathogen guide the hosts to behave differentially against microbial pathogenicity.

IMPORTANCE

Vaccination and immunotherapies against fungal pathogens still remain a challenge. Here, we show using an model based on outbred mice that development of antibodies against Pep1p, an antigenic protein of the fungal pathogen , confers resistance to this fungal infection. In support of this observation, prophylactic or therapeutic immunization of the mice with recombinant Pep1p could improve their survival when infected with a lethal dose of . Moreover, passive therapy with monoclonal anti-Pep1p antibodies also enhanced survival of the mice from infection. The associated antifungal mechanisms were mounting of a protective immune response and the development of fungal specific antibodies that decrease the fungal burden due to an increase in their phagocytosis and/or inhibit the fungal multiplication. Together, our study demonstrates (a) the mode of host-fungal interaction and the immune response developed thereby play a crucial role in developing resistance against ; (b) Pep1p, an aspartic protease as well as an antigenic protein secreted by , can be exploited for vaccination (both prophylactic and therapeutic) or immunotherapy to improve the host defense during this fungal infection.